Orli Shvartzman

Orli Shvartzman, MBA, is currently the Director of Corporate Financial Planning & Analysis at Balt. With extensive experience in financial planning and analysis, Orli has held various roles in companies such as Inozyme Pharma, Lantheus Medical Imaging, and BiOM®. Orli is known for establishing FP&A functions, creating financial models, and supporting key presentations and reporting packages. With a background in economics and logistics, Orli brings a strong analytical and strategic mindset to the table.